دوره 11، شماره 4 - ( 10-1402 )                   جلد 11 شماره 4 صفحات 18-11 | برگشت به فهرست نسخه ها


XML English Abstract Print


Download citation:
BibTeX | RIS | EndNote | Medlars | ProCite | Reference Manager | RefWorks
Send citation to:

Abbasi F, Mortazavi N, Behnampour N, Mohammadi M, Mohammadi S. Serum and salivary microRNA-31 in early detection of head and neck squamous cell carcinoma: A systematic review and meta-analysis. Jorjani Biomed J 2023; 11 (4) :11-18
URL: http://goums.ac.ir/jorjanijournal/article-1-996-fa.html
Serum and salivary microRNA-31 in early detection of head and neck squamous cell carcinoma: A systematic review and meta-analysis. فصلنامه علمی پژوهشی زیست پزشکی جرجانی. 1402; 11 (4) :11-18

URL: http://goums.ac.ir/jorjanijournal/article-1-996-fa.html


چکیده:   (1581 مشاهده)
Background: Oral cancer is the sixth most common cancer in the world and the third most common cancer in developing countries. Early detection of oral cancer can reduce mortality in several ways. The aim of the present study was to combine the quantitative results of various studies concerning serum and salivary microRNAs for early diagnosis of head and neck squamous cell carcinoma (HNSCC).
Methods: This systematic review and meta-analysis was conducted based on the Preferred Reporting Items for Systematic Reviews and Meta-Analyses (PRISMA) Guideline. We searched all the relevant English studies in international databases of PubMed/Medline, Scopus, Web of Science, Cochrane, ProQuest, Embase, and Wiley until February 2022. A random-effects model was used to estimate the pooled odds ratio (OR) and its corresponding 95% confidence interval (CI) for each study. A total of 672 articles were found. After screening, 93 articles were approved for systematic review. Finally, 5 completely relevant articles were examined in the meta-analysis.
Results: Considering all studies regarding miRNAs, the combined results indicated that AUC  =  0.73, with a sensitivity of 71.68% and a specificity of 69.95%, could be used for HNSCC diagnosis. Due to the moderate sensitivity and specificity of miRNAs, they may be able to confirm or exclude suspected cases of this disease, enhancing their utility as clinical diagnostic indicators.
Conclusion: The available data provide evidence that miRNAs, especially MiR-31 expression in the saliva, serum, or plasma, can be used as a diagnostic biomarker for HNSCC patients. However, controlled clinical trials with large sample sizes are needed to validate different miRNAs.
متن کامل [PDF 688 kb]   (439 دریافت)    
نوع مقاله: مرور نظام مند و متا آنالیز | موضوع مقاله: علوم پایه پزشکی
دریافت: 1402/8/6 | پذیرش: 1402/9/25 | انتشار: 1402/10/6

ارسال نظر درباره این مقاله : نام کاربری یا پست الکترونیک شما:
CAPTCHA

بازنشر اطلاعات
Creative Commons License این مقاله تحت شرایط Creative Commons Attribution-NonCommercial 4.0 International License قابل بازنشر است.

کلیه حقوق این وب سایت متعلق به مجله زیست پزشکی جرجانی می باشد.

طراحی و برنامه نویسی : یکتاوب افزار شرق

© 2024 CC BY-NC 4.0 | Jorjani Biomedicine Journal

Designed & Developed by : Yektaweb